image
Collegium Pharmaceutical, Inc. COLL
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 27.05
-2.7 %
$ 869 M
Market Cap
14.53
P/E
INCOME STATEMENT
631 M REVENUE
11.41%
Growth Rates
1Year 11.41%
3Years 31.63%
5Years 16.31%
7Years 55.69%
10Years 0.00%
170 M OPERATING INCOME
1.76%
Growth Rates
1Year 1.76%
3Years 77.98%
5Years 55.71%
7Years 22.97%
10Years 27.79%
69.2 M NET INCOME
43.68%
Growth Rates
1Year 43.68%
3Years -1.10%
5Years 38.22%
7Years 16.57%
10Years 19.34%
EFFICIENCY
Earnings Waterfall Collegium Pharmaceutical, Inc.
image
Revenue 631 M
Cost Of Revenue 254 M
Gross Profit 377 M
Operating Expenses 210 M
Operating Income 170 M
Other Expenses 101 M
Net Income 69.2 M
700m700m600m600m500m500m400m400m300m300m200m200m100m100m00631m(254m)377m(210m)170m(101m)69mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 631.4 566.8 463.9 276.9 310.0 296.7 280.4 28.5 1.7 0 0 0
GROSS PROFIT
Cost Of Revenue 254.1 240.6 254.4 126.3 130.2 193.7 165.7 2.6 0.2 0.2 0 0
Gross Profit 377.3 326.2 209.5 150.6 179.8 103.0 114.7 25.9 1.5 (0.2) 0 0
OPERATING INCOME
Operating Expenses 210.4 150.7 176.2 128.4 123.6 126.8 135.4 101.3 95.6 26.9 17.7 16.0
Selling, General and Administrative Expenses 210.4 159.2 172.2 119.0 113.8 116.4 126.8 92.8 80.6 18.9 2.7 1.9
Research and Development Expenses 0 0 4.0 9.5 9.8 10.3 8.7 8.6 14.9 8.0 15.0 14.2
Operating Income 169.9 167.0 (104.6) (46.7) (5.1) (23.7) (20.7) (75.4) (94.1) (26.9) (17.7) (16.0)
PRE-TAX INCOME
Interest Income Expense 74.0 83.3 63.2 21.0 28.9 0.9 20.1 0.6 94 K 0.4 0.3 76 K
Total Other Income (71.3) (91.2) (62.2) (21.0) (28.6) 1.0 (18.4) 0.6 94 K (0.3) (0.3) (0.2)
Pre-Tax Income 98.6 75.7 (28.8) (3.4) 27.6 (22.7) (39.1) (74.9) (94.2) (27.3) (17.9) (16.2)
NET INCOME
Tax Provision 29.4 27.6 (3.8) (74.9) 0.8 (14.6) (110.9) (1.2) 94 K 91 K 0.3 79 K
Net Income 69.2 48.2 (25.0) 71.5 26.8 (8.1) (39.1) (74.9) (94.2) (27.3) (17.9) (16.2)
EPS 2.14 1.6 0.74 2.05 0.78 0.24 1.19 2.47 3.88 2.01 2.4 2.17